PARSIPPANY, N.J.–(BUSINESS WIRE)–The Medicines Company (NASDAQ:MDCO) today announced that it has entered into a definitive agreement to sell Cleviprex® (clevidipine), Kengreal® (cangrelor) and the Company’s rights to Argatroban for Injection […]

New York, May 5, 2016 – Sudler New York, part of the S&H Group, a leading global healthcare communications organization, is pleased to announce the appointment of Allen Singer as […]

Former agency presidents Frank X. Powers and Lorna Weir launch multidisciplinary strategy lab to serve the pharma, biotech and medical device sectors.

Collaboration will combine WAVE’s proprietary antisense and RNAi capabilities with GalNAc and Pfizer’s hepatic targeting technology for potential development of optimized therapeutics   May 05, 2016 07:01 AM Eastern Daylight […]

Based on the closing of IMS Health and Quintiles common stock prices on May 2, 2016, the equity market capitalization of the joined companies is more than $17.6 billion and the enterprise value is more than $23 billion.